drugset
drugset / Trial / NCT06083116

Drug-Drug Interaction Study Between Henagliflozin Proline and Hydrochlorothiazide

NCT06083116 ↗

Phase 1 Completed 12 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

A single-center, single-arm, open-label, multi-dose, three-period study was conducted in healthy Chinese volunteers.

Timeline

Start
2019-08-28
Primary completion
2019-10-10
Completion
2019-10-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Henagliflozin Small molecule 10 mg —
Subject Hydrochlorothiazide Unknown 25 mg —

Indications

type 2 diabetes mellitus